Broad platform investing across technology and healthcare
NEA's 2026 signal remains broad but consistent: large opportunities at the intersection of enterprise software, healthcare innovation, and AI-enabled infrastructure. The firm's latest fund scale reinforces a multi-stage approach across company lifecycles.
NEA continues to prioritize healthcare delivery modernization and biotech innovation with strong technical differentiation.
Durable enterprise software with clear buyer ROI remains central to the strategy.
AI infrastructure and application layers are investable where deployment quality and reliability are defensible.
Capital scale and market conditions raised the bar on execution, capital efficiency, and repeatable adoption.
Use this entry point to review how NEA engages with early teams.
Contact NEASource: NEA
Last updated: January 25, 2026